SAVIENT PHARMACEUTICALS INC
WKN: 813149 / ISIN: US80517Q1004Savient Pharmaceuticals (WKN 813149)
23.07.09 16:06
#27
iceman78
Performance seit Threadbeginn: + 137,50 %
Die Reise ist aber noch lange nicht vorbei.....
denkt an meine Worte.....
denkt an meine Worte.....
Angehängte Grafik:
savient_top.gif

savient_top.gif
03.08.09 13:06
#29
iceman78
Ahead of the Bell: FDA rejects Savient gout drug
F***, war leider kein Zulassungszock!
FDA says Savient must address manufacturing issues for gout drug Krystexxa before approval
Obwohl hier kurzfristig über 150% möglich gewsesen sind, siehe Threadperformance, macht die FDA einen Strich durch die Rechnung!
Shares fell $5.89, or 38 percent, to $9.70 in premarket trading.
Schade, auf zum nächsten Zock!
http://finance.yahoo.com/news/...-FDA-rejects-apf-1803540982.html?x=0
FDA says Savient must address manufacturing issues for gout drug Krystexxa before approval
Obwohl hier kurzfristig über 150% möglich gewsesen sind, siehe Threadperformance, macht die FDA einen Strich durch die Rechnung!
Shares fell $5.89, or 38 percent, to $9.70 in premarket trading.
Schade, auf zum nächsten Zock!
http://finance.yahoo.com/news/...-FDA-rejects-apf-1803540982.html?x=0
03.08.09 14:25
#30
Chalifmann3
Hi Iceman,
Ich hoffe du bist in dem scheiss nicht investiert,ich habe nie verstanden,warum Savient so hoch bewertet war ....
MFg
Chali
MFg
Chali
03.08.09 14:44
#31
iceman78
Seit letzter Woche nicht mehr....
Schade trotzdem!
lg
Der heutige Tag ist nicht meiner.....
lg
Der heutige Tag ist nicht meiner.....
08.08.12 17:08
#36
crivit
O.o - Bin mit kleiner Posi rein - GLTA
http://de.advfn.com/...&t=17&dm=0&vol=1&cb=1136389482
08.08.12 17:16
#37
crivit
bzgl. des shareholders rights plan (poison pill)
Savient jumps 14% after earnings report
BOSTON (MarketWatch) -- Shares of Savient Pharmaceuticals SVNT +15.95% jumped 14% to 66 cents a share on Wednesday after the biotech group posted a narrowed second-quarter loss. The stock has risen 8% over the last 30 days but has plunged 70% since the beginning of the year. Earlier this week, Savient adopted a shareholders rights plan to deter a possible hostile takeover by stakeholder Tang Capital Partners. Earlier this year, Tang had asserted that Savient was insolvent. On Wednesday, Savient stated it ended the second quarter with $142.2 million in cash and short-term securities. Savient's revenues largely come from its recently approved gout drug Krystexxa, which had sales of $4 million for the second quarter.
http://www.marketwatch.com/story/...s-report-2012-08-08?siteid=yhoof2
BOSTON (MarketWatch) -- Shares of Savient Pharmaceuticals SVNT +15.95% jumped 14% to 66 cents a share on Wednesday after the biotech group posted a narrowed second-quarter loss. The stock has risen 8% over the last 30 days but has plunged 70% since the beginning of the year. Earlier this week, Savient adopted a shareholders rights plan to deter a possible hostile takeover by stakeholder Tang Capital Partners. Earlier this year, Tang had asserted that Savient was insolvent. On Wednesday, Savient stated it ended the second quarter with $142.2 million in cash and short-term securities. Savient's revenues largely come from its recently approved gout drug Krystexxa, which had sales of $4 million for the second quarter.
http://www.marketwatch.com/story/...s-report-2012-08-08?siteid=yhoof2
09.08.12 07:03
#38
crivit
Earnings Call Transcript
CEO Discusses Q2 2012 Results - Earnings Call Transcript
http://seekingalpha.com/article/...nings-call-transcript?source=yahoo
http://seekingalpha.com/article/...nings-call-transcript?source=yahoo
17.08.12 09:16
#41
crivit
Artikel vom 25. Oktober 2010
Aus der heutige Sicht, sieht es doch sehr attraktiv aus. IMO
Bin gespannt.
GLTA ;)
Bristol-Myers Squibb Co. and Novartis AG both looked at acquiring Savient and passed because of concern about price, according to two people with knowledge of the matter, who declined to be identified because the talks are private. The board of directors will continue to “evaluate strategic alternatives,” Savient said in a statement today.
http://www.bloomberg.com/news/2010-10-25/...g-company.html?cmpid=yhoo
http://messages.finance.yahoo.com/Stocks_(A_to_Z)/...tof=15&frt=2
Bin gespannt.
GLTA ;)
Bristol-Myers Squibb Co. and Novartis AG both looked at acquiring Savient and passed because of concern about price, according to two people with knowledge of the matter, who declined to be identified because the talks are private. The board of directors will continue to “evaluate strategic alternatives,” Savient said in a statement today.
http://www.bloomberg.com/news/2010-10-25/...g-company.html?cmpid=yhoo
http://messages.finance.yahoo.com/Stocks_(A_to_Z)/...tof=15&frt=2
11.09.12 08:12
#42
crivit
Form SC 13G/A Statement of Beneficial Ownership
BlackRock Inc. hat aufgestockt!!
Amount beneficially owned:
3113521
Percent of class
4.27%
SC 13G/A amended statement of beneficial ownership 09-10-12
http://investor.savient.com/sec.cfm
Amount beneficially owned:
3113521
Percent of class
4.27%
SC 13G/A amended statement of beneficial ownership 09-10-12
http://investor.savient.com/sec.cfm
12.09.12 09:17
#43
crivit
Savient Pharma: The Pharma Rising From The Dead
Sehr netter Seeking Alpha Artikel über die aktuelle Situation.
http://seekingalpha.com/article/...-rising-from-the-dead?source=yahoo
http://seekingalpha.com/article/...-rising-from-the-dead?source=yahoo
12.09.12 15:41
#44
crivit
O.o
Whauuuuuu, zu Beginn sofort ein 400k Kauf!!!
Munter geht das Treiben weiter! ;)Zieehhhhh
Munter geht das Treiben weiter! ;)Zieehhhhh
18.09.12 07:37
#46
crivit
21.09.12 European EMA
http://www.biopharmcatalyst.com/ema-calendar/
22.09.12 10:49
#48
crivit
:)
Für einen Freitag ein verdammt guter Lauf.
After Hours: 2,54$
Volumen 13.600
http://www.nasdaq.com/symbol/svnt/after-hours
After Hours: 2,54$
Volumen 13.600
http://www.nasdaq.com/symbol/svnt/after-hours
19.10.12 14:03
#49
crivit
EMA News?
Kommt sie heute, ich bin gespannt.
http://www.biopharmcatalyst.com/ema-calendar/
http://www.biopharmcatalyst.com/ema-calendar/
19.10.12 22:34
#50
crivit
News
Savient Receives Positive CHMP Opinion for KRYSTEXXA® Approval in the EU
http://finance.yahoo.com/news/...positive-chmp-opinion-145000794.html
http://finance.yahoo.com/news/...positive-chmp-opinion-145000794.html
Seite:
1
|
1
|
2

